Edition:
United Kingdom

INC Research Holdings Inc (INCR.OQ)

INCR.OQ on NASDAQ Stock Exchange Global Select Market

40.95USD
4:41pm GMT
Change (% chg)

$-0.10 (-0.24%)
Prev Close
$41.05
Open
$41.35
Day's High
$41.65
Day's Low
$40.95
Volume
67,412
Avg. Vol
285,427
52-wk High
$61.05
52-wk Low
$33.65

Chart for

About

INC Research Holdings, Inc. is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical... (more)

Overall

Beta: --
Market Cap(Mil.): $5,637.00
Shares Outstanding(Mil.): 103.53
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Inc Research Holdings qtrly GAAP diluted loss per share of $1.70‍​

* Inc Research Holdings - Net service revenue for the three months ended September 30, 2017 increased by $332.7 million, or 128.2%, to $592.2 million‍​

09 Nov 2017

BRIEF-INC Research Holdings Inc says on August 1, 2017, co entered into credit agreement

* INC Research Holdings Inc says on August 1, 2017, Inc Research Holdings, Inc entered into credit agreement - SEC filing

01 Aug 2017

EQT to acquire pharmaceutical services firm Certara

Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm.

11 Jul 2017

UPDATE 1-EQT to acquire pharmaceutical services firm Certara

July 11 Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm.

11 Jul 2017

Earnings vs. Estimates